Canada's Tilray Goes Global With Novartis Pot Partnership

The video discusses the significance of partnerships between cannabis companies like Tilray and major industry players such as Novartis, highlighting the validation of cannabis use on a global scale. It contrasts the recreational and medicinal cannabis markets, emphasizing the financial attractiveness of the medical sector. The discussion also covers the potential for growth in countries outside North America that are legalizing medical cannabis.

What is the significance of the deal between Novartis and Tilray in the cannabis industry?

How does Tilray differentiate itself from other Canadian LPs in the cannabis market?

What are the prospects for the medicinal and pharmacological side of the cannabis industry?

What early evidence is being seen in Germany regarding the medical cannabis opportunity?

What is the potential market for medical cannabis outside of North America?